Hospira, Inc., et al. v. Eurohealth International SARL, et al., C.A. Nos. 14-487 – GMS; C.A. No. 14-1008- GMS, November 3, 2015.

Sleet, J.   Claim construction opinion issues regarding two terms from one patent.

The disputed technology relates to dexmedetomidine and its pharmaceutically acceptable salts.   The following term was considered:

1. “dexmedetomidine”
2. “loading dose”